Cassella James V 4
4 · Trevi Therapeutics, Inc. · Filed Jun 23, 2022
Insider Transaction Report
Form 4
Cassella James V
Chief Development Officer
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2022-06-23+20,000→ 20,000 totalExercise: $2.27Exp: 2032-06-22→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 23, 2022. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.